Apheresis market – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2034

7.82%
CAGR (2026-2034)
2.40 USD Bn.
Forecast Market Size
312
Report Pages
142
Market Tables

Overview

Apheresis Market CAGR is expected to be 7.82% during the forecast period and the market size is expected to reach nearly US$ 4.73 Bn. by 2034.

The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

Apheresis is the medical technology which is used for the purification of the blood or separation of different components of blood. It involves removal of the blood from the donor or patients and collecting it into an apparatus which separates the desired component from the blood, while the rest of the blood is sent back to the donor or patients.

The rising prevalence of diseases and a growing number of trauma and injury cases, increasing demand for source plasma from biopharmaceutical companies, and the presence of a favorable reimbursement scenario for apheresis would create commercial market opportunities. Untapped emerging regions showcase new growth opportunities for this market. Lack of awareness about apheresis and the high cost of these procedures. Blood and blood products can get infected easily. This risk along with a lack of skilled professionals is the major hindrance for market growth.

 Apheresis Market Size, Share and Growth AnalysisApheresis Market Growth

To know about the Research Methodology :- Request Free Sample Report

Apheresis market is segmented by product, procedure, technology, application, and region. Among products, plasma component separators is considered an attractive market segment and are expected to hold a significant share of the market in the coming years. Growth can be attributed to factors such as the increase in incidence rate of chronic disorders and weak immune system among people. Immunoadsorption Columns segment would continue to dominate the market during the forecast period owing to the growing demand for kidney transplantation.

Among the procedure segment, therapeutic apheresis is considered an attractive market segment and is expected to hold a significant share of the market in the coming years. It is used for the treatment of conditions in which a pathogenic substance or component in the blood is causing morbidity. Growth can be attributed to factors such as the treatment of conditions in which a pathogenic substance or component in the blood is causing morbidity.

Among regions, the North America region is expected to grow at the highest CAGR during the forecast period due to increasing applications of apheresis products in plasma collection and fractionation. The presence of established distribution channels and the growing focus on apheresis blood collection to overcome blood shortage is driving the market growth in this region. The Asia Pacific is expected to grow rapidly due to rapid development in healthcare and increasing healthcare expenditure.

The major key players in Apheresis market include Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan). In 2018, Fresenius Medical Care achieved a preclinical milestone in its regenerative medicine program for chronic kidney disease.

Apheresis Market report Scope:Inquire before buying

Global Apheresis Market
Report Coverage Details
Base Year: 2025 Forecast Period: 2026-2034
Historical Data: 2020 to 2025 Market Size in 2025: US $
2.40 Bn.
Forecast Period 2026 to 2034 CAGR: 7.82 % Market Size in 2034: US $ 4.73  Bn.
Segments Covered: by Product Apheresis Devices
Plasma Separators
Plasma Component Separators
Immunoadsorption Columns
Plasma Perfusion Columns
Hemoperfusion Columns
Apheresis Disposables
Apheresis Market, by Procedure
Automated/Apheresis Blood Collection (Donor Apheresis)
Therapeutic Apheresis
by Disease Neurological Disorders
Blood Disorders
Cardiovascular Disorders
Renal Disorders
Autoimmune Disorders
Metabolic Disorders
Other Disorders
by Procedure Therapeutic Plasma Exchange (TPE)
Therapeutic Cytapheresis
Therapeutic Erythrocytapheresis
Therapeutic Plateletpheresis
Leukapheresis
Photopheresis
Extracorporeal Immunoadsorption (ECI)
by Technology Centrifugation
Intermittent Flow
Continuous Flow
Membrane Separation
by Application Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukapheresis
Other Applications

Apheresis market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Apheresis Market Key Players:

1. Haemonetics Corporation
2. Fresenius Medical Care
3. Terumo BCT, Inc.
4. Asahi Kasei Medical Co., Ltd.
5. Kawasumi Laboratories Inc.
6. Cerus Corporation
7. B. Braun Melsungen AG
8. HemaCare Corporation
9. Kaneka Corporation
10. Nikkiso Co., Ltd.

Frequently Asked Questions:

1. Which region has the largest share in Global Apheresis Market?
Ans: North America region holds the highest share in 2025.

2. What is the growth rate of Global Apheresis Market?
Ans: The Global Apheresis Market is growing at a CAGR of 7.82% during forecasting period 2024-2034.

3. What is scope of the Global Apheresis market report?
Ans: Global Apheresis Market report helps with the PESTEL, PORTER,  Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Apheresis market?
Ans: The important key players in the Global Apheresis Market are – Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, Inc., Asahi Kasei Medical Co., Ltd., Kawasumi Laboratories Inc., Cerus Corporation, B. Braun Melsungen AG, HemaCare Corporation, Kaneka Corporation, Nikkiso Co., and Ltd.

5. What is the study period of this market?
Ans: The Global Apheresis Market is studied from 2020 to 2034.

Table of Contents

1. Apheresis Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Apheresis Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2025) 2.3.5. Company Locations 2.4. Leading Apheresis Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Apheresis Market: Dynamics 3.1. Apheresis Market Trends by Region 3.1.1. North America Apheresis Market Trends 3.1.2. Europe Apheresis Market Trends 3.1.3. Asia Pacific Apheresis Market Trends 3.1.4. Middle East and Africa Apheresis Market Trends 3.1.5. South America Apheresis Market Trends 3.2. Apheresis Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Apheresis Market Drivers 3.2.1.2. North America Apheresis Market Restraints 3.2.1.3. North America Apheresis Market Opportunities 3.2.1.4. North America Apheresis Market Challenges 3.2.2. Europe 3.2.2.1. Europe Apheresis Market Drivers 3.2.2.2. Europe Apheresis Market Restraints 3.2.2.3. Europe Apheresis Market Opportunities 3.2.2.4. Europe Apheresis Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Apheresis Market Drivers 3.2.3.2. Asia Pacific Apheresis Market Restraints 3.2.3.3. Asia Pacific Apheresis Market Opportunities 3.2.3.4. Asia Pacific Apheresis Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Apheresis Market Drivers 3.2.4.2. Middle East and Africa Apheresis Market Restraints 3.2.4.3. Middle East and Africa Apheresis Market Opportunities 3.2.4.4. Middle East and Africa Apheresis Market Challenges 3.2.5. South America 3.2.5.1. South America Apheresis Market Drivers 3.2.5.2. South America Apheresis Market Restraints 3.2.5.3. South America Apheresis Market Opportunities 3.2.5.4. South America Apheresis Market Challenges 3.3. PORTER's Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis in the Apheresis Market 3.8. Analysis of Government Schemes and Initiatives For Global Industry 3.9. Apheresis Market Trade Analysis 3.10. The Global Pandemic Impact on Apheresis Market 4. Apheresis Market: Global Market Size and Forecast by Segmentation (in Billion) 2025-2034 4.1. Apheresis Market Size and Forecast, by Product (2025-2034) 4.1.1. Apheresis Devices 4.1.2. Plasma Separators 4.1.3. Plasma Component Separators 4.1.4. Immunoadsorption Columns 4.1.5. Plasma Perfusion Columns 4.1.6. Hemoperfusion Columns 4.1.7. Apheresis Disposables 4.1.8. Apheresis Market, by Procedure 4.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 4.1.10. Therapeutic Apheresis 4.2. Apheresis Market Size and Forecast, by Disease (2025-2034) 4.2.1. Neurological Disorders 4.2.2. Blood Disorders 4.2.3. Cardiovascular Disorders 4.2.4. Renal Disorders 4.2.5. Autoimmune Disorders 4.2.6. Metabolic Disorders 4.2.7. Other Disorders 4.3. Apheresis Market Size and Forecast, by Procedure (2025-2034) 4.3.1. Therapeutic Plasma Exchange (TPE) 4.3.2. Therapeutic Cytapheresis 4.3.3. Therapeutic Erythrocytapheresis 4.3.4. Therapeutic Plateletpheresis 4.3.5. Leukapheresis 4.3.6. Photopheresis 4.3.7. Extracorporeal Immunoadsorption (ECI) 4.4. Apheresis Market Size and Forecast, by Region (2025-2034) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Apheresis Market Size and Forecast by Segmentation (in Billion) 2025-2034 5.1. North America Apheresis Market Size and Forecast, by Product (2025-2034) 5.1.1. Apheresis Devices 5.1.2. Plasma Separators 5.1.3. Plasma Component Separators 5.1.4. Immunoadsorption Columns 5.1.5. Plasma Perfusion Columns 5.1.6. Hemoperfusion Columns 5.1.7. Apheresis Disposables 5.1.8. Apheresis Market, by Procedure 5.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 5.1.10. Therapeutic Apheresis 5.2. North America Apheresis Market Size and Forecast, by Disease (2025-2034) 5.2.1. Neurological Disorders 5.2.2. Blood Disorders 5.2.3. Cardiovascular Disorders 5.2.4. Renal Disorders 5.2.5. Autoimmune Disorders 5.2.6. Metabolic Disorders 5.2.7. Other Disorders 5.3. North America Apheresis Market Size and Forecast, by Procedure (2025-2034) 5.3.1. Therapeutic Plasma Exchange (TPE) 5.3.2. Therapeutic Cytapheresis 5.3.3. Therapeutic Erythrocytapheresis 5.3.4. Therapeutic Plateletpheresis 5.3.5. Leukapheresis 5.3.6. Photopheresis 5.3.7. Extracorporeal Immunoadsorption (ECI) 5.4. North America Apheresis Market Size and Forecast, by Country (2025-2034) 5.4.1. United States 5.4.1.1. United States Apheresis Market Size and Forecast, by Product (2025-2034) 5.4.1.1.1. Apheresis Devices 5.4.1.1.2. Plasma Separators 5.4.1.1.3. Plasma Component Separators 5.4.1.1.4. Immunoadsorption Columns 5.4.1.1.5. Plasma Perfusion Columns 5.4.1.1.6. Hemoperfusion Columns 5.4.1.1.7. Apheresis Disposables 5.4.1.1.8. Apheresis Market, by Procedure 5.4.1.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 5.4.1.1.10. Therapeutic Apheresis 5.4.1.2. United States Apheresis Market Size and Forecast, by Disease (2025-2034) 5.4.1.2.1. Neurological Disorders 5.4.1.2.2. Blood Disorders 5.4.1.2.3. Cardiovascular Disorders 5.4.1.2.4. Renal Disorders 5.4.1.2.5. Autoimmune Disorders 5.4.1.2.6. Metabolic Disorders 5.4.1.2.7. Other Disorders 5.4.1.3. United States Apheresis Market Size and Forecast, by Procedure (2025-2034) 5.4.1.3.1. Therapeutic Plasma Exchange (TPE) 5.4.1.3.2. Therapeutic Cytapheresis 5.4.1.3.3. Therapeutic Erythrocytapheresis 5.4.1.3.4. Therapeutic Plateletpheresis 5.4.1.3.5. Leukapheresis 5.4.1.3.6. Photopheresis 5.4.1.3.7. Extracorporeal Immunoadsorption (ECI) 5.4.2. Canada 5.4.2.1. Canada Apheresis Market Size and Forecast, by Product (2025-2034) 5.4.2.1.1. Apheresis Devices 5.4.2.1.2. Plasma Separators 5.4.2.1.3. Plasma Component Separators 5.4.2.1.4. Immunoadsorption Columns 5.4.2.1.5. Plasma Perfusion Columns 5.4.2.1.6. Hemoperfusion Columns 5.4.2.1.7. Apheresis Disposables 5.4.2.1.8. Apheresis Market, by Procedure 5.4.2.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 5.4.2.1.10. Therapeutic Apheresis 5.4.2.2. Canada Apheresis Market Size and Forecast, by Disease (2025-2034) 5.4.2.2.1. Neurological Disorders 5.4.2.2.2. Blood Disorders 5.4.2.2.3. Cardiovascular Disorders 5.4.2.2.4. Renal Disorders 5.4.2.2.5. Autoimmune Disorders 5.4.2.2.6. Metabolic Disorders 5.4.2.2.7. Other Disorders 5.4.2.3. Canada Apheresis Market Size and Forecast, by Procedure (2025-2034) 5.4.2.3.1. Therapeutic Plasma Exchange (TPE) 5.4.2.3.2. Therapeutic Cytapheresis 5.4.2.3.3. Therapeutic Erythrocytapheresis 5.4.2.3.4. Therapeutic Plateletpheresis 5.4.2.3.5. Leukapheresis 5.4.2.3.6. Photopheresis 5.4.2.3.7. Extracorporeal Immunoadsorption (ECI) 5.4.3. Mexico 5.4.3.1. Mexico Apheresis Market Size and Forecast, by Product (2025-2034) 5.4.3.1.1. Apheresis Devices 5.4.3.1.2. Plasma Separators 5.4.3.1.3. Plasma Component Separators 5.4.3.1.4. Immunoadsorption Columns 5.4.3.1.5. Plasma Perfusion Columns 5.4.3.1.6. Hemoperfusion Columns 5.4.3.1.7. Apheresis Disposables 5.4.3.1.8. Apheresis Market, by Procedure 5.4.3.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 5.4.3.1.10. Therapeutic Apheresis 5.4.3.2. Mexico Apheresis Market Size and Forecast, by Disease (2025-2034) 5.4.3.2.1. Neurological Disorders 5.4.3.2.2. Blood Disorders 5.4.3.2.3. Cardiovascular Disorders 5.4.3.2.4. Renal Disorders 5.4.3.2.5. Autoimmune Disorders 5.4.3.2.6. Metabolic Disorders 5.4.3.2.7. Other Disorders 5.4.3.3. Mexico Apheresis Market Size and Forecast, by Procedure (2025-2034) 5.4.3.3.1. Therapeutic Plasma Exchange (TPE) 5.4.3.3.2. Therapeutic Cytapheresis 5.4.3.3.3. Therapeutic Erythrocytapheresis 5.4.3.3.4. Therapeutic Plateletpheresis 5.4.3.3.5. Leukapheresis 5.4.3.3.6. Photopheresis 5.4.3.3.7. Extracorporeal Immunoadsorption (ECI) 6. Europe Apheresis Market Size and Forecast by Segmentation (in Billion) 2025-2034 6.1. Europe Apheresis Market Size and Forecast, by Product (2025-2034) 6.1.1. Apheresis Devices 6.1.2. Plasma Separators 6.1.3. Plasma Component Separators 6.1.4. Immunoadsorption Columns 6.1.5. Plasma Perfusion Columns 6.1.6. Hemoperfusion Columns 6.1.7. Apheresis Disposables 6.1.8. Apheresis Market, by Procedure 6.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 6.1.10. Therapeutic Apheresis 6.2. Europe Apheresis Market Size and Forecast, by Disease (2025-2034) 6.2.1. Neurological Disorders 6.2.2. Blood Disorders 6.2.3. Cardiovascular Disorders 6.2.4. Renal Disorders 6.2.5. Autoimmune Disorders 6.2.6. Metabolic Disorders 6.2.7. Other Disorders 6.3. Europe Apheresis Market Size and Forecast, by Procedure (2025-2034) 6.3.1. Therapeutic Plasma Exchange (TPE) 6.3.2. Therapeutic Cytapheresis 6.3.3. Therapeutic Erythrocytapheresis 6.3.4. Therapeutic Plateletpheresis 6.3.5. Leukapheresis 6.3.6. Photopheresis 6.3.7. Extracorporeal Immunoadsorption (ECI) 6.4. Europe Apheresis Market Size and Forecast, by Country (2025-2034) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Apheresis Market Size and Forecast, by Product (2025-2034) 6.4.1.1.1. Apheresis Devices 6.4.1.1.2. Plasma Separators 6.4.1.1.3. Plasma Component Separators 6.4.1.1.4. Immunoadsorption Columns 6.4.1.1.5. Plasma Perfusion Columns 6.4.1.1.6. Hemoperfusion Columns 6.4.1.1.7. Apheresis Disposables 6.4.1.1.8. Apheresis Market, by Procedure 6.4.1.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 6.4.1.1.10. Therapeutic Apheresis 6.4.1.2. United Kingdom Apheresis Market Size and Forecast, by Disease (2025-2034) 6.4.1.2.1. Neurological Disorders 6.4.1.2.2. Blood Disorders 6.4.1.2.3. Cardiovascular Disorders 6.4.1.2.4. Renal Disorders 6.4.1.2.5. Autoimmune Disorders 6.4.1.2.6. Metabolic Disorders 6.4.1.2.7. Other Disorders 6.4.1.3. United Kingdom Apheresis Market Size and Forecast, by Procedure (2025-2034) 6.4.1.3.1. Therapeutic Plasma Exchange (TPE) 6.4.1.3.2. Therapeutic Cytapheresis 6.4.1.3.3. Therapeutic Erythrocytapheresis 6.4.1.3.4. Therapeutic Plateletpheresis 6.4.1.3.5. Leukapheresis 6.4.1.3.6. Photopheresis 6.4.1.3.7. Extracorporeal Immunoadsorption (ECI) 6.4.2. France 6.4.2.1. France Apheresis Market Size and Forecast, by Product (2025-2034) 6.4.2.1.1. Apheresis Devices 6.4.2.1.2. Plasma Separators 6.4.2.1.3. Plasma Component Separators 6.4.2.1.4. Immunoadsorption Columns 6.4.2.1.5. Plasma Perfusion Columns 6.4.2.1.6. Hemoperfusion Columns 6.4.2.1.7. Apheresis Disposables 6.4.2.1.8. Apheresis Market, by Procedure 6.4.2.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 6.4.2.1.10. Therapeutic Apheresis 6.4.2.2. France Apheresis Market Size and Forecast, by Disease (2025-2034) 6.4.2.2.1. Neurological Disorders 6.4.2.2.2. Blood Disorders 6.4.2.2.3. Cardiovascular Disorders 6.4.2.2.4. Renal Disorders 6.4.2.2.5. Autoimmune Disorders 6.4.2.2.6. Metabolic Disorders 6.4.2.2.7. Other Disorders 6.4.2.3. France Apheresis Market Size and Forecast, by Procedure (2025-2034) 6.4.2.3.1. Therapeutic Plasma Exchange (TPE) 6.4.2.3.2. Therapeutic Cytapheresis 6.4.2.3.3. Therapeutic Erythrocytapheresis 6.4.2.3.4. Therapeutic Plateletpheresis 6.4.2.3.5. Leukapheresis 6.4.2.3.6. Photopheresis 6.4.2.3.7. Extracorporeal Immunoadsorption (ECI) 6.4.3. Germany 6.4.3.1. Germany Apheresis Market Size and Forecast, by Product (2025-2034) 6.4.3.1.1. Apheresis Devices 6.4.3.1.2. Plasma Separators 6.4.3.1.3. Plasma Component Separators 6.4.3.1.4. Immunoadsorption Columns 6.4.3.1.5. Plasma Perfusion Columns 6.4.3.1.6. Hemoperfusion Columns 6.4.3.1.7. Apheresis Disposables 6.4.3.1.8. Apheresis Market, by Procedure 6.4.3.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 6.4.3.1.10. Therapeutic Apheresis 6.4.3.2. Germany Apheresis Market Size and Forecast, by Disease (2025-2034) 6.4.3.2.1. Neurological Disorders 6.4.3.2.2. Blood Disorders 6.4.3.2.3. Cardiovascular Disorders 6.4.3.2.4. Renal Disorders 6.4.3.2.5. Autoimmune Disorders 6.4.3.2.6. Metabolic Disorders 6.4.3.2.7. Other Disorders 6.4.3.3. Germany Apheresis Market Size and Forecast, by Procedure (2025-2034) 6.4.3.3.1. Therapeutic Plasma Exchange (TPE) 6.4.3.3.2. Therapeutic Cytapheresis 6.4.3.3.3. Therapeutic Erythrocytapheresis 6.4.3.3.4. Therapeutic Plateletpheresis 6.4.3.3.5. Leukapheresis 6.4.3.3.6. Photopheresis 6.4.3.3.7. Extracorporeal Immunoadsorption (ECI) 6.4.4. Italy 6.4.4.1. Italy Apheresis Market Size and Forecast, by Product (2025-2034) 6.4.4.1.1. Apheresis Devices 6.4.4.1.2. Plasma Separators 6.4.4.1.3. Plasma Component Separators 6.4.4.1.4. Immunoadsorption Columns 6.4.4.1.5. Plasma Perfusion Columns 6.4.4.1.6. Hemoperfusion Columns 6.4.4.1.7. Apheresis Disposables 6.4.4.1.8. Apheresis Market, by Procedure 6.4.4.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 6.4.4.1.10. Therapeutic Apheresis 6.4.4.2. Italy Apheresis Market Size and Forecast, by Disease (2025-2034) 6.4.4.2.1. Neurological Disorders 6.4.4.2.2. Blood Disorders 6.4.4.2.3. Cardiovascular Disorders 6.4.4.2.4. Renal Disorders 6.4.4.2.5. Autoimmune Disorders 6.4.4.2.6. Metabolic Disorders 6.4.4.2.7. Other Disorders 6.4.4.3. Italy Apheresis Market Size and Forecast, by Procedure (2025-2034) 6.4.4.3.1. Therapeutic Plasma Exchange (TPE) 6.4.4.3.2. Therapeutic Cytapheresis 6.4.4.3.3. Therapeutic Erythrocytapheresis 6.4.4.3.4. Therapeutic Plateletpheresis 6.4.4.3.5. Leukapheresis 6.4.4.3.6. Photopheresis 6.4.4.3.7. Extracorporeal Immunoadsorption (ECI) 6.4.5. Spain 6.4.5.1. Spain Apheresis Market Size and Forecast, by Product (2025-2034) 6.4.5.1.1. Apheresis Devices 6.4.5.1.2. Plasma Separators 6.4.5.1.3. Plasma Component Separators 6.4.5.1.4. Immunoadsorption Columns 6.4.5.1.5. Plasma Perfusion Columns 6.4.5.1.6. Hemoperfusion Columns 6.4.5.1.7. Apheresis Disposables 6.4.5.1.8. Apheresis Market, by Procedure 6.4.5.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 6.4.5.1.10. Therapeutic Apheresis 6.4.5.2. Spain Apheresis Market Size and Forecast, by Disease (2025-2034) 6.4.5.2.1. Neurological Disorders 6.4.5.2.2. Blood Disorders 6.4.5.2.3. Cardiovascular Disorders 6.4.5.2.4. Renal Disorders 6.4.5.2.5. Autoimmune Disorders 6.4.5.2.6. Metabolic Disorders 6.4.5.2.7. Other Disorders 6.4.5.3. Spain Apheresis Market Size and Forecast, by Procedure (2025-2034) 6.4.5.3.1. Therapeutic Plasma Exchange (TPE) 6.4.5.3.2. Therapeutic Cytapheresis 6.4.5.3.3. Therapeutic Erythrocytapheresis 6.4.5.3.4. Therapeutic Plateletpheresis 6.4.5.3.5. Leukapheresis 6.4.5.3.6. Photopheresis 6.4.5.3.7. Extracorporeal Immunoadsorption (ECI) 6.4.6. Sweden 6.4.6.1. Sweden Apheresis Market Size and Forecast, by Product (2025-2034) 6.4.6.1.1. Apheresis Devices 6.4.6.1.2. Plasma Separators 6.4.6.1.3. Plasma Component Separators 6.4.6.1.4. Immunoadsorption Columns 6.4.6.1.5. Plasma Perfusion Columns 6.4.6.1.6. Hemoperfusion Columns 6.4.6.1.7. Apheresis Disposables 6.4.6.1.8. Apheresis Market, by Procedure 6.4.6.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 6.4.6.1.10. Therapeutic Apheresis 6.4.6.2. Sweden Apheresis Market Size and Forecast, by Disease (2025-2034) 6.4.6.2.1. Neurological Disorders 6.4.6.2.2. Blood Disorders 6.4.6.2.3. Cardiovascular Disorders 6.4.6.2.4. Renal Disorders 6.4.6.2.5. Autoimmune Disorders 6.4.6.2.6. Metabolic Disorders 6.4.6.2.7. Other Disorders 6.4.6.3. Sweden Apheresis Market Size and Forecast, by Procedure (2025-2034) 6.4.6.3.1. Therapeutic Plasma Exchange (TPE) 6.4.6.3.2. Therapeutic Cytapheresis 6.4.6.3.3. Therapeutic Erythrocytapheresis 6.4.6.3.4. Therapeutic Plateletpheresis 6.4.6.3.5. Leukapheresis 6.4.6.3.6. Photopheresis 6.4.6.3.7. Extracorporeal Immunoadsorption (ECI) 6.4.7. Austria 6.4.7.1. Austria Apheresis Market Size and Forecast, by Product (2025-2034) 6.4.7.1.1. Apheresis Devices 6.4.7.1.2. Plasma Separators 6.4.7.1.3. Plasma Component Separators 6.4.7.1.4. Immunoadsorption Columns 6.4.7.1.5. Plasma Perfusion Columns 6.4.7.1.6. Hemoperfusion Columns 6.4.7.1.7. Apheresis Disposables 6.4.7.1.8. Apheresis Market, by Procedure 6.4.7.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 6.4.7.1.10. Therapeutic Apheresis 6.4.7.2. Austria Apheresis Market Size and Forecast, by Disease (2025-2034) 6.4.7.2.1. Neurological Disorders 6.4.7.2.2. Blood Disorders 6.4.7.2.3. Cardiovascular Disorders 6.4.7.2.4. Renal Disorders 6.4.7.2.5. Autoimmune Disorders 6.4.7.2.6. Metabolic Disorders 6.4.7.2.7. Other Disorders 6.4.7.3. Austria Apheresis Market Size and Forecast, by Procedure (2025-2034) 6.4.7.3.1. Therapeutic Plasma Exchange (TPE) 6.4.7.3.2. Therapeutic Cytapheresis 6.4.7.3.3. Therapeutic Erythrocytapheresis 6.4.7.3.4. Therapeutic Plateletpheresis 6.4.7.3.5. Leukapheresis 6.4.7.3.6. Photopheresis 6.4.7.3.7. Extracorporeal Immunoadsorption (ECI) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Apheresis Market Size and Forecast, by Product (2025-2034) 6.4.8.1.1. Apheresis Devices 6.4.8.1.2. Plasma Separators 6.4.8.1.3. Plasma Component Separators 6.4.8.1.4. Immunoadsorption Columns 6.4.8.1.5. Plasma Perfusion Columns 6.4.8.1.6. Hemoperfusion Columns 6.4.8.1.7. Apheresis Disposables 6.4.8.1.8. Apheresis Market, by Procedure 6.4.8.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 6.4.8.1.10. Therapeutic Apheresis 6.4.8.2. Rest of Europe Apheresis Market Size and Forecast, by Disease (2025-2034) 6.4.8.2.1. Neurological Disorders 6.4.8.2.2. Blood Disorders 6.4.8.2.3. Cardiovascular Disorders 6.4.8.2.4. Renal Disorders 6.4.8.2.5. Autoimmune Disorders 6.4.8.2.6. Metabolic Disorders 6.4.8.2.7. Other Disorders 6.4.8.3. Rest of Europe Apheresis Market Size and Forecast, by Procedure (2025-2034) 6.4.8.3.1. Therapeutic Plasma Exchange (TPE) 6.4.8.3.2. Therapeutic Cytapheresis 6.4.8.3.3. Therapeutic Erythrocytapheresis 6.4.8.3.4. Therapeutic Plateletpheresis 6.4.8.3.5. Leukapheresis 6.4.8.3.6. Photopheresis 6.4.8.3.7. Extracorporeal Immunoadsorption (ECI) 7. Asia Pacific Apheresis Market Size and Forecast by Segmentation (in Billion) 2025-2034 7.1. Asia Pacific Apheresis Market Size and Forecast, by Product (2025-2034) 7.1.1. Apheresis Devices 7.1.2. Plasma Separators 7.1.3. Plasma Component Separators 7.1.4. Immunoadsorption Columns 7.1.5. Plasma Perfusion Columns 7.1.6. Hemoperfusion Columns 7.1.7. Apheresis Disposables 7.1.8. Apheresis Market, by Procedure 7.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.1.10. Therapeutic Apheresis 7.2. Asia Pacific Apheresis Market Size and Forecast, by Disease (2025-2034) 7.2.1. Neurological Disorders 7.2.2. Blood Disorders 7.2.3. Cardiovascular Disorders 7.2.4. Renal Disorders 7.2.5. Autoimmune Disorders 7.2.6. Metabolic Disorders 7.2.7. Other Disorders 7.3. Asia Pacific Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.3.1. Therapeutic Plasma Exchange (TPE) 7.3.2. Therapeutic Cytapheresis 7.3.3. Therapeutic Erythrocytapheresis 7.3.4. Therapeutic Plateletpheresis 7.3.5. Leukapheresis 7.3.6. Photopheresis 7.3.7. Extracorporeal Immunoadsorption (ECI) 7.4. Asia Pacific Apheresis Market Size and Forecast, by Country (2025-2034) 7.4.1. China 7.4.1.1. China Apheresis Market Size and Forecast, by Product (2025-2034) 7.4.1.1.1. Apheresis Devices 7.4.1.1.2. Plasma Separators 7.4.1.1.3. Plasma Component Separators 7.4.1.1.4. Immunoadsorption Columns 7.4.1.1.5. Plasma Perfusion Columns 7.4.1.1.6. Hemoperfusion Columns 7.4.1.1.7. Apheresis Disposables 7.4.1.1.8. Apheresis Market, by Procedure 7.4.1.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.4.1.1.10. Therapeutic Apheresis 7.4.1.2. China Apheresis Market Size and Forecast, by Disease (2025-2034) 7.4.1.2.1. Neurological Disorders 7.4.1.2.2. Blood Disorders 7.4.1.2.3. Cardiovascular Disorders 7.4.1.2.4. Renal Disorders 7.4.1.2.5. Autoimmune Disorders 7.4.1.2.6. Metabolic Disorders 7.4.1.2.7. Other Disorders 7.4.1.3. China Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.4.1.3.1. Therapeutic Plasma Exchange (TPE) 7.4.1.3.2. Therapeutic Cytapheresis 7.4.1.3.3. Therapeutic Erythrocytapheresis 7.4.1.3.4. Therapeutic Plateletpheresis 7.4.1.3.5. Leukapheresis 7.4.1.3.6. Photopheresis 7.4.1.3.7. Extracorporeal Immunoadsorption (ECI) 7.4.2. S Korea 7.4.2.1. S Korea Apheresis Market Size and Forecast, by Product (2025-2034) 7.4.2.1.1. Apheresis Devices 7.4.2.1.2. Plasma Separators 7.4.2.1.3. Plasma Component Separators 7.4.2.1.4. Immunoadsorption Columns 7.4.2.1.5. Plasma Perfusion Columns 7.4.2.1.6. Hemoperfusion Columns 7.4.2.1.7. Apheresis Disposables 7.4.2.1.8. Apheresis Market, by Procedure 7.4.2.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.4.2.1.10. Therapeutic Apheresis 7.4.2.2. S Korea Apheresis Market Size and Forecast, by Disease (2025-2034) 7.4.2.2.1. Neurological Disorders 7.4.2.2.2. Blood Disorders 7.4.2.2.3. Cardiovascular Disorders 7.4.2.2.4. Renal Disorders 7.4.2.2.5. Autoimmune Disorders 7.4.2.2.6. Metabolic Disorders 7.4.2.2.7. Other Disorders 7.4.2.3. S Korea Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.4.2.3.1. Therapeutic Plasma Exchange (TPE) 7.4.2.3.2. Therapeutic Cytapheresis 7.4.2.3.3. Therapeutic Erythrocytapheresis 7.4.2.3.4. Therapeutic Plateletpheresis 7.4.2.3.5. Leukapheresis 7.4.2.3.6. Photopheresis 7.4.2.3.7. Extracorporeal Immunoadsorption (ECI) 7.4.3. Japan 7.4.3.1. Japan Apheresis Market Size and Forecast, by Product (2025-2034) 7.4.3.1.1. Apheresis Devices 7.4.3.1.2. Plasma Separators 7.4.3.1.3. Plasma Component Separators 7.4.3.1.4. Immunoadsorption Columns 7.4.3.1.5. Plasma Perfusion Columns 7.4.3.1.6. Hemoperfusion Columns 7.4.3.1.7. Apheresis Disposables 7.4.3.1.8. Apheresis Market, by Procedure 7.4.3.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.4.3.1.10. Therapeutic Apheresis 7.4.3.2. Japan Apheresis Market Size and Forecast, by Disease (2025-2034) 7.4.3.2.1. Neurological Disorders 7.4.3.2.2. Blood Disorders 7.4.3.2.3. Cardiovascular Disorders 7.4.3.2.4. Renal Disorders 7.4.3.2.5. Autoimmune Disorders 7.4.3.2.6. Metabolic Disorders 7.4.3.2.7. Other Disorders 7.4.3.3. Japan Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.4.3.3.1. Therapeutic Plasma Exchange (TPE) 7.4.3.3.2. Therapeutic Cytapheresis 7.4.3.3.3. Therapeutic Erythrocytapheresis 7.4.3.3.4. Therapeutic Plateletpheresis 7.4.3.3.5. Leukapheresis 7.4.3.3.6. Photopheresis 7.4.3.3.7. Extracorporeal Immunoadsorption (ECI) 7.4.4. India 7.4.4.1. India Apheresis Market Size and Forecast, by Product (2025-2034) 7.4.4.1.1. Apheresis Devices 7.4.4.1.2. Plasma Separators 7.4.4.1.3. Plasma Component Separators 7.4.4.1.4. Immunoadsorption Columns 7.4.4.1.5. Plasma Perfusion Columns 7.4.4.1.6. Hemoperfusion Columns 7.4.4.1.7. Apheresis Disposables 7.4.4.1.8. Apheresis Market, by Procedure 7.4.4.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.4.4.1.10. Therapeutic Apheresis 7.4.4.2. India Apheresis Market Size and Forecast, by Disease (2025-2034) 7.4.4.2.1. Neurological Disorders 7.4.4.2.2. Blood Disorders 7.4.4.2.3. Cardiovascular Disorders 7.4.4.2.4. Renal Disorders 7.4.4.2.5. Autoimmune Disorders 7.4.4.2.6. Metabolic Disorders 7.4.4.2.7. Other Disorders 7.4.4.3. India Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.4.4.3.1. Therapeutic Plasma Exchange (TPE) 7.4.4.3.2. Therapeutic Cytapheresis 7.4.4.3.3. Therapeutic Erythrocytapheresis 7.4.4.3.4. Therapeutic Plateletpheresis 7.4.4.3.5. Leukapheresis 7.4.4.3.6. Photopheresis 7.4.4.3.7. Extracorporeal Immunoadsorption (ECI) 7.4.5. Australia 7.4.5.1. Australia Apheresis Market Size and Forecast, by Product (2025-2034) 7.4.5.1.1. Apheresis Devices 7.4.5.1.2. Plasma Separators 7.4.5.1.3. Plasma Component Separators 7.4.5.1.4. Immunoadsorption Columns 7.4.5.1.5. Plasma Perfusion Columns 7.4.5.1.6. Hemoperfusion Columns 7.4.5.1.7. Apheresis Disposables 7.4.5.1.8. Apheresis Market, by Procedure 7.4.5.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.4.5.1.10. Therapeutic Apheresis 7.4.5.2. Australia Apheresis Market Size and Forecast, by Disease (2025-2034) 7.4.5.2.1. Neurological Disorders 7.4.5.2.2. Blood Disorders 7.4.5.2.3. Cardiovascular Disorders 7.4.5.2.4. Renal Disorders 7.4.5.2.5. Autoimmune Disorders 7.4.5.2.6. Metabolic Disorders 7.4.5.2.7. Other Disorders 7.4.5.3. Australia Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.4.5.3.1. Therapeutic Plasma Exchange (TPE) 7.4.5.3.2. Therapeutic Cytapheresis 7.4.5.3.3. Therapeutic Erythrocytapheresis 7.4.5.3.4. Therapeutic Plateletpheresis 7.4.5.3.5. Leukapheresis 7.4.5.3.6. Photopheresis 7.4.5.3.7. Extracorporeal Immunoadsorption (ECI) 7.4.6. Indonesia 7.4.6.1. Indonesia Apheresis Market Size and Forecast, by Product (2025-2034) 7.4.6.1.1. Apheresis Devices 7.4.6.1.2. Plasma Separators 7.4.6.1.3. Plasma Component Separators 7.4.6.1.4. Immunoadsorption Columns 7.4.6.1.5. Plasma Perfusion Columns 7.4.6.1.6. Hemoperfusion Columns 7.4.6.1.7. Apheresis Disposables 7.4.6.1.8. Apheresis Market, by Procedure 7.4.6.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.4.6.1.10. Therapeutic Apheresis 7.4.6.2. Indonesia Apheresis Market Size and Forecast, by Disease (2025-2034) 7.4.6.2.1. Neurological Disorders 7.4.6.2.2. Blood Disorders 7.4.6.2.3. Cardiovascular Disorders 7.4.6.2.4. Renal Disorders 7.4.6.2.5. Autoimmune Disorders 7.4.6.2.6. Metabolic Disorders 7.4.6.2.7. Other Disorders 7.4.6.3. Indonesia Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.4.6.3.1. Therapeutic Plasma Exchange (TPE) 7.4.6.3.2. Therapeutic Cytapheresis 7.4.6.3.3. Therapeutic Erythrocytapheresis 7.4.6.3.4. Therapeutic Plateletpheresis 7.4.6.3.5. Leukapheresis 7.4.6.3.6. Photopheresis 7.4.6.3.7. Extracorporeal Immunoadsorption (ECI) 7.4.7. Malaysia 7.4.7.1. Malaysia Apheresis Market Size and Forecast, by Product (2025-2034) 7.4.7.1.1. Apheresis Devices 7.4.7.1.2. Plasma Separators 7.4.7.1.3. Plasma Component Separators 7.4.7.1.4. Immunoadsorption Columns 7.4.7.1.5. Plasma Perfusion Columns 7.4.7.1.6. Hemoperfusion Columns 7.4.7.1.7. Apheresis Disposables 7.4.7.1.8. Apheresis Market, by Procedure 7.4.7.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.4.7.1.10. Therapeutic Apheresis 7.4.7.2. Malaysia Apheresis Market Size and Forecast, by Disease (2025-2034) 7.4.7.2.1. Neurological Disorders 7.4.7.2.2. Blood Disorders 7.4.7.2.3. Cardiovascular Disorders 7.4.7.2.4. Renal Disorders 7.4.7.2.5. Autoimmune Disorders 7.4.7.2.6. Metabolic Disorders 7.4.7.2.7. Other Disorders 7.4.7.3. Malaysia Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.4.7.3.1. Therapeutic Plasma Exchange (TPE) 7.4.7.3.2. Therapeutic Cytapheresis 7.4.7.3.3. Therapeutic Erythrocytapheresis 7.4.7.3.4. Therapeutic Plateletpheresis 7.4.7.3.5. Leukapheresis 7.4.7.3.6. Photopheresis 7.4.7.3.7. Extracorporeal Immunoadsorption (ECI) 7.4.8. Vietnam 7.4.8.1. Vietnam Apheresis Market Size and Forecast, by Product (2025-2034) 7.4.8.1.1. Apheresis Devices 7.4.8.1.2. Plasma Separators 7.4.8.1.3. Plasma Component Separators 7.4.8.1.4. Immunoadsorption Columns 7.4.8.1.5. Plasma Perfusion Columns 7.4.8.1.6. Hemoperfusion Columns 7.4.8.1.7. Apheresis Disposables 7.4.8.1.8. Apheresis Market, by Procedure 7.4.8.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.4.8.1.10. Therapeutic Apheresis 7.4.8.2. Vietnam Apheresis Market Size and Forecast, by Disease (2025-2034) 7.4.8.2.1. Neurological Disorders 7.4.8.2.2. Blood Disorders 7.4.8.2.3. Cardiovascular Disorders 7.4.8.2.4. Renal Disorders 7.4.8.2.5. Autoimmune Disorders 7.4.8.2.6. Metabolic Disorders 7.4.8.2.7. Other Disorders 7.4.8.3. Vietnam Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.4.8.3.1. Therapeutic Plasma Exchange (TPE) 7.4.8.3.2. Therapeutic Cytapheresis 7.4.8.3.3. Therapeutic Erythrocytapheresis 7.4.8.3.4. Therapeutic Plateletpheresis 7.4.8.3.5. Leukapheresis 7.4.8.3.6. Photopheresis 7.4.8.3.7. Extracorporeal Immunoadsorption (ECI) 7.4.9. Taiwan 7.4.9.1. Taiwan Apheresis Market Size and Forecast, by Product (2025-2034) 7.4.9.1.1. Apheresis Devices 7.4.9.1.2. Plasma Separators 7.4.9.1.3. Plasma Component Separators 7.4.9.1.4. Immunoadsorption Columns 7.4.9.1.5. Plasma Perfusion Columns 7.4.9.1.6. Hemoperfusion Columns 7.4.9.1.7. Apheresis Disposables 7.4.9.1.8. Apheresis Market, by Procedure 7.4.9.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.4.9.1.10. Therapeutic Apheresis 7.4.9.2. Taiwan Apheresis Market Size and Forecast, by Disease (2025-2034) 7.4.9.2.1. Neurological Disorders 7.4.9.2.2. Blood Disorders 7.4.9.2.3. Cardiovascular Disorders 7.4.9.2.4. Renal Disorders 7.4.9.2.5. Autoimmune Disorders 7.4.9.2.6. Metabolic Disorders 7.4.9.2.7. Other Disorders 7.4.9.3. Taiwan Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.4.9.3.1. Therapeutic Plasma Exchange (TPE) 7.4.9.3.2. Therapeutic Cytapheresis 7.4.9.3.3. Therapeutic Erythrocytapheresis 7.4.9.3.4. Therapeutic Plateletpheresis 7.4.9.3.5. Leukapheresis 7.4.9.3.6. Photopheresis 7.4.9.3.7. Extracorporeal Immunoadsorption (ECI) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Apheresis Market Size and Forecast, by Product (2025-2034) 7.4.10.1.1. Apheresis Devices 7.4.10.1.2. Plasma Separators 7.4.10.1.3. Plasma Component Separators 7.4.10.1.4. Immunoadsorption Columns 7.4.10.1.5. Plasma Perfusion Columns 7.4.10.1.6. Hemoperfusion Columns 7.4.10.1.7. Apheresis Disposables 7.4.10.1.8. Apheresis Market, by Procedure 7.4.10.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 7.4.10.1.10. Therapeutic Apheresis 7.4.10.2. Rest of Asia Pacific Apheresis Market Size and Forecast, by Disease (2025-2034) 7.4.10.2.1. Neurological Disorders 7.4.10.2.2. Blood Disorders 7.4.10.2.3. Cardiovascular Disorders 7.4.10.2.4. Renal Disorders 7.4.10.2.5. Autoimmune Disorders 7.4.10.2.6. Metabolic Disorders 7.4.10.2.7. Other Disorders 7.4.10.3. Rest of Asia Pacific Apheresis Market Size and Forecast, by Procedure (2025-2034) 7.4.10.3.1. Therapeutic Plasma Exchange (TPE) 7.4.10.3.2. Therapeutic Cytapheresis 7.4.10.3.3. Therapeutic Erythrocytapheresis 7.4.10.3.4. Therapeutic Plateletpheresis 7.4.10.3.5. Leukapheresis 7.4.10.3.6. Photopheresis 7.4.10.3.7. Extracorporeal Immunoadsorption (ECI) 8. Middle East and Africa Apheresis Market Size and Forecast by Segmentation (in Billion) 2025-2034 8.1. Middle East and Africa Apheresis Market Size and Forecast, by Product (2025-2034) 8.1.1. Apheresis Devices 8.1.2. Plasma Separators 8.1.3. Plasma Component Separators 8.1.4. Immunoadsorption Columns 8.1.5. Plasma Perfusion Columns 8.1.6. Hemoperfusion Columns 8.1.7. Apheresis Disposables 8.1.8. Apheresis Market, by Procedure 8.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 8.1.10. Therapeutic Apheresis 8.2. Middle East and Africa Apheresis Market Size and Forecast, by Disease (2025-2034) 8.2.1. Neurological Disorders 8.2.2. Blood Disorders 8.2.3. Cardiovascular Disorders 8.2.4. Renal Disorders 8.2.5. Autoimmune Disorders 8.2.6. Metabolic Disorders 8.2.7. Other Disorders 8.3. Middle East and Africa Apheresis Market Size and Forecast, by Procedure (2025-2034) 8.3.1. Therapeutic Plasma Exchange (TPE) 8.3.2. Therapeutic Cytapheresis 8.3.3. Therapeutic Erythrocytapheresis 8.3.4. Therapeutic Plateletpheresis 8.3.5. Leukapheresis 8.3.6. Photopheresis 8.3.7. Extracorporeal Immunoadsorption (ECI) 8.4. Middle East and Africa Apheresis Market Size and Forecast, by Country (2025-2034) 8.4.1. South Africa 8.4.1.1. South Africa Apheresis Market Size and Forecast, by Product (2025-2034) 8.4.1.1.1. Apheresis Devices 8.4.1.1.2. Plasma Separators 8.4.1.1.3. Plasma Component Separators 8.4.1.1.4. Immunoadsorption Columns 8.4.1.1.5. Plasma Perfusion Columns 8.4.1.1.6. Hemoperfusion Columns 8.4.1.1.7. Apheresis Disposables 8.4.1.1.8. Apheresis Market, by Procedure 8.4.1.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 8.4.1.1.10. Therapeutic Apheresis 8.4.1.2. South Africa Apheresis Market Size and Forecast, by Disease (2025-2034) 8.4.1.2.1. Neurological Disorders 8.4.1.2.2. Blood Disorders 8.4.1.2.3. Cardiovascular Disorders 8.4.1.2.4. Renal Disorders 8.4.1.2.5. Autoimmune Disorders 8.4.1.2.6. Metabolic Disorders 8.4.1.2.7. Other Disorders 8.4.1.3. South Africa Apheresis Market Size and Forecast, by Procedure (2025-2034) 8.4.1.3.1. Therapeutic Plasma Exchange (TPE) 8.4.1.3.2. Therapeutic Cytapheresis 8.4.1.3.3. Therapeutic Erythrocytapheresis 8.4.1.3.4. Therapeutic Plateletpheresis 8.4.1.3.5. Leukapheresis 8.4.1.3.6. Photopheresis 8.4.1.3.7. Extracorporeal Immunoadsorption (ECI) 8.4.2. GCC 8.4.2.1. GCC Apheresis Market Size and Forecast, by Product (2025-2034) 8.4.2.1.1. Apheresis Devices 8.4.2.1.2. Plasma Separators 8.4.2.1.3. Plasma Component Separators 8.4.2.1.4. Immunoadsorption Columns 8.4.2.1.5. Plasma Perfusion Columns 8.4.2.1.6. Hemoperfusion Columns 8.4.2.1.7. Apheresis Disposables 8.4.2.1.8. Apheresis Market, by Procedure 8.4.2.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 8.4.2.1.10. Therapeutic Apheresis 8.4.2.2. GCC Apheresis Market Size and Forecast, by Disease (2025-2034) 8.4.2.2.1. Neurological Disorders 8.4.2.2.2. Blood Disorders 8.4.2.2.3. Cardiovascular Disorders 8.4.2.2.4. Renal Disorders 8.4.2.2.5. Autoimmune Disorders 8.4.2.2.6. Metabolic Disorders 8.4.2.2.7. Other Disorders 8.4.2.3. GCC Apheresis Market Size and Forecast, by Procedure (2025-2034) 8.4.2.3.1. Therapeutic Plasma Exchange (TPE) 8.4.2.3.2. Therapeutic Cytapheresis 8.4.2.3.3. Therapeutic Erythrocytapheresis 8.4.2.3.4. Therapeutic Plateletpheresis 8.4.2.3.5. Leukapheresis 8.4.2.3.6. Photopheresis 8.4.2.3.7. Extracorporeal Immunoadsorption (ECI) 8.4.3. Nigeria 8.4.3.1. Nigeria Apheresis Market Size and Forecast, by Product (2025-2034) 8.4.3.1.1. Apheresis Devices 8.4.3.1.2. Plasma Separators 8.4.3.1.3. Plasma Component Separators 8.4.3.1.4. Immunoadsorption Columns 8.4.3.1.5. Plasma Perfusion Columns 8.4.3.1.6. Hemoperfusion Columns 8.4.3.1.7. Apheresis Disposables 8.4.3.1.8. Apheresis Market, by Procedure 8.4.3.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 8.4.3.1.10. Therapeutic Apheresis 8.4.3.2. Nigeria Apheresis Market Size and Forecast, by Disease (2025-2034) 8.4.3.2.1. Neurological Disorders 8.4.3.2.2. Blood Disorders 8.4.3.2.3. Cardiovascular Disorders 8.4.3.2.4. Renal Disorders 8.4.3.2.5. Autoimmune Disorders 8.4.3.2.6. Metabolic Disorders 8.4.3.2.7. Other Disorders 8.4.3.3. Nigeria Apheresis Market Size and Forecast, by Procedure (2025-2034) 8.4.3.3.1. Therapeutic Plasma Exchange (TPE) 8.4.3.3.2. Therapeutic Cytapheresis 8.4.3.3.3. Therapeutic Erythrocytapheresis 8.4.3.3.4. Therapeutic Plateletpheresis 8.4.3.3.5. Leukapheresis 8.4.3.3.6. Photopheresis 8.4.3.3.7. Extracorporeal Immunoadsorption (ECI) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Apheresis Market Size and Forecast, by Product (2025-2034) 8.4.4.1.1. Apheresis Devices 8.4.4.1.2. Plasma Separators 8.4.4.1.3. Plasma Component Separators 8.4.4.1.4. Immunoadsorption Columns 8.4.4.1.5. Plasma Perfusion Columns 8.4.4.1.6. Hemoperfusion Columns 8.4.4.1.7. Apheresis Disposables 8.4.4.1.8. Apheresis Market, by Procedure 8.4.4.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 8.4.4.1.10. Therapeutic Apheresis 8.4.4.2. Rest of ME&A Apheresis Market Size and Forecast, by Disease (2025-2034) 8.4.4.2.1. Neurological Disorders 8.4.4.2.2. Blood Disorders 8.4.4.2.3. Cardiovascular Disorders 8.4.4.2.4. Renal Disorders 8.4.4.2.5. Autoimmune Disorders 8.4.4.2.6. Metabolic Disorders 8.4.4.2.7. Other Disorders 8.4.4.3. Rest of ME&A Apheresis Market Size and Forecast, by Procedure (2025-2034) 8.4.4.3.1. Therapeutic Plasma Exchange (TPE) 8.4.4.3.2. Therapeutic Cytapheresis 8.4.4.3.3. Therapeutic Erythrocytapheresis 8.4.4.3.4. Therapeutic Plateletpheresis 8.4.4.3.5. Leukapheresis 8.4.4.3.6. Photopheresis 8.4.4.3.7. Extracorporeal Immunoadsorption (ECI) 9. South America Apheresis Market Size and Forecast by Segmentation (in Billion) 2025-2034 9.1. South America Apheresis Market Size and Forecast, by Product (2025-2034) 9.1.1. Apheresis Devices 9.1.2. Plasma Separators 9.1.3. Plasma Component Separators 9.1.4. Immunoadsorption Columns 9.1.5. Plasma Perfusion Columns 9.1.6. Hemoperfusion Columns 9.1.7. Apheresis Disposables 9.1.8. Apheresis Market, by Procedure 9.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 9.1.10. Therapeutic Apheresis 9.2. South America Apheresis Market Size and Forecast, by Disease (2025-2034) 9.2.1. Neurological Disorders 9.2.2. Blood Disorders 9.2.3. Cardiovascular Disorders 9.2.4. Renal Disorders 9.2.5. Autoimmune Disorders 9.2.6. Metabolic Disorders 9.2.7. Other Disorders 9.3. South America Apheresis Market Size and Forecast, by Procedure (2025-2034) 9.3.1. Therapeutic Plasma Exchange (TPE) 9.3.2. Therapeutic Cytapheresis 9.3.3. Therapeutic Erythrocytapheresis 9.3.4. Therapeutic Plateletpheresis 9.3.5. Leukapheresis 9.3.6. Photopheresis 9.3.7. Extracorporeal Immunoadsorption (ECI) 9.4. South America Apheresis Market Size and Forecast, by Country (2025-2034) 9.4.1. Brazil 9.4.1.1. Brazil Apheresis Market Size and Forecast, by Product (2025-2034) 9.4.1.1.1. Apheresis Devices 9.4.1.1.2. Plasma Separators 9.4.1.1.3. Plasma Component Separators 9.4.1.1.4. Immunoadsorption Columns 9.4.1.1.5. Plasma Perfusion Columns 9.4.1.1.6. Hemoperfusion Columns 9.4.1.1.7. Apheresis Disposables 9.4.1.1.8. Apheresis Market, by Procedure 9.4.1.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 9.4.1.1.10. Therapeutic Apheresis 9.4.1.2. Brazil Apheresis Market Size and Forecast, by Disease (2025-2034) 9.4.1.2.1. Neurological Disorders 9.4.1.2.2. Blood Disorders 9.4.1.2.3. Cardiovascular Disorders 9.4.1.2.4. Renal Disorders 9.4.1.2.5. Autoimmune Disorders 9.4.1.2.6. Metabolic Disorders 9.4.1.2.7. Other Disorders 9.4.1.3. Brazil Apheresis Market Size and Forecast, by Procedure (2025-2034) 9.4.1.3.1. Therapeutic Plasma Exchange (TPE) 9.4.1.3.2. Therapeutic Cytapheresis 9.4.1.3.3. Therapeutic Erythrocytapheresis 9.4.1.3.4. Therapeutic Plateletpheresis 9.4.1.3.5. Leukapheresis 9.4.1.3.6. Photopheresis 9.4.1.3.7. Extracorporeal Immunoadsorption (ECI) 9.4.2. Argentina 9.4.2.1. Argentina Apheresis Market Size and Forecast, by Product (2025-2034) 9.4.2.1.1. Apheresis Devices 9.4.2.1.2. Plasma Separators 9.4.2.1.3. Plasma Component Separators 9.4.2.1.4. Immunoadsorption Columns 9.4.2.1.5. Plasma Perfusion Columns 9.4.2.1.6. Hemoperfusion Columns 9.4.2.1.7. Apheresis Disposables 9.4.2.1.8. Apheresis Market, by Procedure 9.4.2.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 9.4.2.1.10. Therapeutic Apheresis 9.4.2.2. Argentina Apheresis Market Size and Forecast, by Disease (2025-2034) 9.4.2.2.1. Neurological Disorders 9.4.2.2.2. Blood Disorders 9.4.2.2.3. Cardiovascular Disorders 9.4.2.2.4. Renal Disorders 9.4.2.2.5. Autoimmune Disorders 9.4.2.2.6. Metabolic Disorders 9.4.2.2.7. Other Disorders 9.4.2.3. Argentina Apheresis Market Size and Forecast, by Procedure (2025-2034) 9.4.2.3.1. Therapeutic Plasma Exchange (TPE) 9.4.2.3.2. Therapeutic Cytapheresis 9.4.2.3.3. Therapeutic Erythrocytapheresis 9.4.2.3.4. Therapeutic Plateletpheresis 9.4.2.3.5. Leukapheresis 9.4.2.3.6. Photopheresis 9.4.2.3.7. Extracorporeal Immunoadsorption (ECI) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Apheresis Market Size and Forecast, by Product (2025-2034) 9.4.3.1.1. Apheresis Devices 9.4.3.1.2. Plasma Separators 9.4.3.1.3. Plasma Component Separators 9.4.3.1.4. Immunoadsorption Columns 9.4.3.1.5. Plasma Perfusion Columns 9.4.3.1.6. Hemoperfusion Columns 9.4.3.1.7. Apheresis Disposables 9.4.3.1.8. Apheresis Market, by Procedure 9.4.3.1.9. Automated/Apheresis Blood Collection (Donor Apheresis) 9.4.3.1.10. Therapeutic Apheresis 9.4.3.2. Rest Of South America Apheresis Market Size and Forecast, by Disease (2025-2034) 9.4.3.2.1. Neurological Disorders 9.4.3.2.2. Blood Disorders 9.4.3.2.3. Cardiovascular Disorders 9.4.3.2.4. Renal Disorders 9.4.3.2.5. Autoimmune Disorders 9.4.3.2.6. Metabolic Disorders 9.4.3.2.7. Other Disorders 9.4.3.3. Rest Of South America Apheresis Market Size and Forecast, by Procedure (2025-2034) 9.4.3.3.1. Therapeutic Plasma Exchange (TPE) 9.4.3.3.2. Therapeutic Cytapheresis 9.4.3.3.3. Therapeutic Erythrocytapheresis 9.4.3.3.4. Therapeutic Plateletpheresis 9.4.3.3.5. Leukapheresis 9.4.3.3.6. Photopheresis 9.4.3.3.7. Extracorporeal Immunoadsorption (ECI) 10. Company Profile: Key Players 10.1. Haemonetics Corporation 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Fresenius Medical Care 10.3. Terumo BCT, Inc. 10.4. Asahi Kasei Medical Co., Ltd. 10.5. Kawasumi Laboratories Inc. 10.6. Cerus Corporation 10.7. B. Braun Melsungen AG 10.8. HemaCare Corporation 10.9. Kaneka Corporation 10.10. Nikkiso Co., Ltd. 11. Key Findings 12. Industry Recommendations 13. Apheresis Market: Research Methodology 14. Terms and Glossary

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Request Customization Download Sample